微小RNA-92a-3p通过靶向血管内皮细胞中的SGK3调控视网膜血管生成
本研究在体内和体外探究微小RNA(miR)-92a-3p对视网膜血管生成的作用及机制。小鼠玻璃体腔注射agomir-92a-3p可抑制视网膜浅层与深层血管丛发育、减少Ki67表达并增加cleaved caspase-3表达;体外过表达miR-92a-3p抑制血管内皮细胞成管、迁移与划痕愈合。在氧诱导视网膜病变(OIR)小鼠中,agomir-92a-3p抑制病理性视网膜新生血管,机制涉及靶向SGK3、p-GSK3β/GSK3β与Bcl-xL。
要点
- 过表达miR-92a-3p抑制小鼠视网膜浅层和深层血管丛发育,并减少视网膜血管内皮细胞Ki67表达、增加cleaved caspase-3表达。
- 体外过表达miR-92a-3p明显抑制培养内皮细胞的成管、细胞迁移和划痕愈合。
- agomir-92a-3p通过靶向SGK3、p-GSK3β/GSK3β和Bcl-xL抑制OIR小鼠病理性视网膜新生血管。
核心结论
- miR-92a-3p可通过靶向SGK3通路影响视网膜血管生成,作者认为miR-92a-3p可能是视网膜血管疾病的潜在抗血管生成因子。
研究设计与样本
- 研究为体内与体外实验:小鼠右眼玻璃体腔注射agomir-92a-3p,左眼注射agomir-NC作为对照,于出生后第3天(P3)、P5、P8注射,于P7、P9、P12进行免疫荧光检查。
- 体外使用人视网膜微血管内皮细胞(HRMECs),分别以mimic-NC和mimic-92a-3p处理,进行成管、细胞迁移和划痕愈合实验。
- OIR小鼠于P12右眼玻璃体腔注射agomir-92a-3p、左眼注射agomir-NC作为对照,P17用异凝集素B4视网膜铺片染色观察新生血管。
- 采用生物信息学和高通量测序鉴定miR-92a-3p的潜在靶基因,用RT-qPCR和Western blot检测HRMECs与小鼠视网膜中SGK3、p-GSK3β、GSK3β、Bcl-xL和cleaved caspase-3的表达。
主要发现
- 过表达miR-92a-3p抑制视网膜浅层血管丛和深层血管丛发育,降低异凝集素B4标记的视网膜血管内皮细胞中Ki67表达,并增加cleaved caspase-3表达。
- 体外过表达miR-92a-3p明显抑制培养内皮细胞的成管、细胞迁移和划痕愈合。
- 过表达miR-92a-3p通过下调SGK3、p-GSK3β/GSK3β和Bcl-xL表达,抑制体内和体外生理性血管生成。
- agomir-92a-3p通过靶向SGK3、p-GSK3β/GSK3β和Bcl-xL,抑制OIR小鼠病理性视网膜新生血管。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to investigate the effects and mechanism of microRNA (miR)-92a-3p in retinal angiogenesis in vitro and in vivo. METHODS: The expression of miR-92a-3p was verified by real-time quantitative polymerase chain reaction (RT-qPCR). Agomir-92a-3p was intravitreally injected into the right eye on postnatal day 3 (P3), P5, and P8 in the mice, with the agomir-NC injected left eye as the control. At P7, P9, and P12, immunofluorescence was performed to examine the retinal superficial vascular plexus, deep vascular plexus, proliferation, and apoptosis in retinal vascular endothelial cells (ECs). Human retinal microvascular endothelial cells (HRMECs) were treated with mimic-NC and mimic-92a-3p, then the tube formation, cell migration, and wound healing assays were used to detect the effect of miR-92a-3p on retinal angiogenesis in vitro. Agomir-92a-3p was also intravitreally injected into the right eye of oxygen-induced retinopathy (OIR) mice at P12, with the agomir-NC injected left eye as the control, the neovascularization was observed by retinal flatmount staining with isolectin B4 at P17. Bioinformatics and high-throughput sequencing were performed to identify potential target genes of miR-92a-3p. RT-qPCR and Western blot were carried out to detect the expression of SGK3, p-GSK3β, GSK3β, Bcl-xL, and cleaved caspase-3 in the HRMECs and mouse retinas. RESULTS: The overexpression of miR-92a-3p inhibited the development of retinal superficial vascular plexus and deep vascular plexus, decreased the expression of Ki67, and increased the expression of cleaved caspase-3 in isolectin B4-labeled retinal vascular ECs. In vitro, the overexpression of miR-92a-3p markedly suppressed the tube formation, cell migration, and wound healing of cultured ECs. Overexpression of miR-92a-3p inhibited both in vivo and in vitro physiological angiogenesis by downregulating the expression of SGK3, p-GSK3β/GSK3β, and Bcl-xL. In addition, agomir-92a-3p inhibited the pathological retinal neovascularization of OIR mice, by targeting SGK3, p-GSK3β/GSK3β, and Bcl-xL. CONCLUSIONS: The miR-92a-3p could affect retinal angiogenesis by targeting SGK3 pathway, suggesting that miR-92a-3p may be a potential anti-angiogenic factor for retinal vascular disease.
引用
- Cui Y, Liu R, Hong Y, et al. MicroRNA-92a-3p Regulates Retinal Angiogenesis by Targeting SGK3 in Vascular Endothelial Cells. Invest Ophthalmol Vis Sci. 2022. PMID: 36269185. doi:10.1167/iovs.63.11.19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。